Preclinical and clinical experience with cisplatin resistance.

Despite the general lack of clinical evidence supporting the preclinical data, there have been many attempts to overcome cisplatin resistance in clinical situations. These efforts have focused on both the proposed mechanisms of resistance as well as novel approaches to renew efficacy. In this article, the authors summarize the available clinical studies that have intentionally or serendipitously uncovered modulators of cisplatin sensitivity.